1. Home
  2. EVO vs PGY Comparison

EVO vs PGY Comparison

Compare EVO & PGY Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Evotec SE

EVO

Evotec SE

HOLD

Current Price

$3.07

Market Cap

1.1B

Sector

Health Care

ML Signal

HOLD

Logo Pagaya Technologies Ltd.

PGY

Pagaya Technologies Ltd.

HOLD

Current Price

$14.83

Market Cap

1.1B

Sector

Finance

ML Signal

HOLD

Company Overview

Basic Information
Metric
EVO
PGY
Founded
1993
2016
Country
Germany
United States
Employees
4553
511
Industry
Biotechnology: Pharmaceutical Preparations
Finance: Consumer Services
Sector
Health Care
Finance
Exchange
Nasdaq
Nasdaq
Market Cap
1.1B
1.1B
IPO Year
N/A
N/A

Fundamental Metrics

Financial Performance
Metric
EVO
PGY
Price
$3.07
$14.83
Analyst Decision
Strong Buy
Strong Buy
Analyst Count
1
8
Target Price
$7.00
$34.50
AVG Volume (30 Days)
47.1K
3.6M
Earning Date
04-08-2026
05-07-2026
Dividend Yield
N/A
N/A
EPS Growth
N/A
N/A
EPS
N/A
N/A
Revenue
N/A
N/A
Revenue This Year
$1.37
$14.27
Revenue Next Year
$10.05
$14.39
P/E Ratio
N/A
$13.54
Revenue Growth
N/A
N/A
52 Week Low
$2.31
$10.40
52 Week High
$4.42
$44.99

Technical Indicators

Market Signals
Indicator
EVO
PGY
Relative Strength Index (RSI) 56.03 59.89
Support Level $2.88 $10.78
Resistance Level $3.75 $15.57
Average True Range (ATR) 0.07 0.83
MACD 0.01 0.05
Stochastic Oscillator 89.58 90.27

Price Performance

Historical Comparison
EVO
PGY

About EVO Evotec SE

Evotec SE is a life science company focused on developing pharmaceutical products through standalone services, integrated R&D programs, and strategic partnerships with pharmaceutical and biotechnology companies, academic institutions, and other partners. It operates across drug discovery, preclinical development, and manufacturing, with expertise in areas including oncology, central nervous system, cardiovascular-renal, immune and inflammatory, infectious, and other diseases. The Company generates revenue through fee-for-service and FTE-based services, milestones, and royalties, and equity ownership in biotechnology and academic projects. It operates through the Shared R&D and Discovery & Preclinical Development (D&PD) segments, with the majority of revenue generated from the USA.

About PGY Pagaya Technologies Ltd.

Pagaya Technologies Ltd is a product-focused technology company. It uses machine learning, a vast data network, and an AI-driven approach to offer comprehensive consumer credit and residential real estate products for its partners, their customers, and investors. Its suite of products includes Decline Monetization, Dual Look, First Look, Affiliate Optimizer Engine, Direct Marketing Engine, and FastPass, providing lenders with an AI-powered credit and acquisition ecosystem that helps them approve more borrowers, capture more demand, and grow without adding risk. Geographically, the company generates maximum revenue from its business in the United States.

Share on Social Networks: